AstraZeneca has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country’s general manager, the Financial Times reported on Friday, citing two people with direct knowledge of the matter.
Thirteen teams took the stage to present their healthcare innovations to a panel of judges and an audience attending in person and online.
Whether transcatheter aortic-valve replacement can improve outcomes in patients with asymptomatic severe aortic stenosis has been unclear. Research findings …
Women doctors from innovative health systems across the U.S. are working to transform health care and advance equity in medicine.
Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price negotiation program under the Inflation Reduction…
Nature Reviews Biodiversity – This Review explores the relationship between emerging infectious diseases and biodiversity loss, and how both are connected to global environmental changes…
This Medical News article discusses the ongoing debate about whether the word cancer should be dropped from the names of indolent tumors of the prostate…
Our editors at MashupMD bring you the latest in medicine, health care, and public health from the leading professionals and journals you trust.
What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are among the areas of interest.
The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public companies.
A report found China limits EU-based device manufacturers’ access to its market through policies that favor local suppliers in an “unfair and discriminatory way.”
